specific HLA binding inhibitors (Avidex)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namespecific HLA binding inhibitors (Avidex)
Drug Alias NameT cell-based GvHD program (Avidex)autoimmune disease program (Avidex)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsGraft vs Host DiseaseAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A